RE: Regional lymphadenopathy following COVID-19 vaccination in patients with or suspicious of breast cancer: A quick summary of current key facts and recommendations

Abstract

We have gained a broader perspective on the management of unilateral lymphadenopathy due to COVID-19 vaccination from the editorial entitled “Regional Lymphadenopathy Following COVID-19 Vaccination in Patients with or Suspicious of Breast Cancer: A Quick Summary of Current Key Facts and Recommendations” by Chang and Ha, recently published in the Korean Journal of Radiology